126: Lexaria Bioscience Chairman and CEO Chris Bunka on Disrupting an Industry, DehydraTECH™, and The Art of Being a CEO

Lexaria Bioscience Chairman and CEO Chris Bunka on Disrupting an Industry, DehydraTECH™, and The Art of Being a CEO

Welcome to episode 126 of Optimal Health For Busy Entrepreneurs.

We have Lexaria Bioscience Chairman and CEO Chris Bunka stopping by for a fascinating discussion on disruption, the art of being a CEO, and their innovative technology DehydraTECH™. DehydraTECH™ improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier delivery methods and increasing the effectiveness of fat-soluble active molecules and drugs. Chris is a published author and was previously a serial entrepreneur for over three decades.


Watch today’s episode:


Listen to today’s episode:


In today’s episode, you’ll hear:

  • Chris’s origin story and what makes him tick
  • The art of being a CEO
  • The thought process behind pivoting Lexaria (and how you can think about pivoting)
  • How Lexaria became what it is today
  • Why you must have your ethics and values in order
  • What is DehydraTECH™
  • The many potential benefits of DehydraTECH™
  • The process to get listed on NASDAQ and some things to expect
  • How Chris goes about adding team members (and the number one thing he looks for)
  • What’s on the horizon for Lexaria
  • Some of the significant health issues Lexaria is attacking
  • Chris’s wellness habits
  • And much more

Connect With Chris:


Connect With Julian: